convalescent

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of…

Physician’s Briefing Staff MONDAY, Aug. 15, 2022 (HealthDay News) -- In a clinical guideline published online Aug. 16 in the Annals of Internal…

Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national…

In the dark days of the early COVID-19 pandemic, when there was no known therapy, COVID-19…

The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School…

The U.S. Food and Drug Administration (FDA) currently authorizes this plasma as a treatment option for outpatients with immunocompromising diseases or receiving immunocompromising…

TUESDAY, Feb. 8, 2022 (HealthDay News) -- High-titer…

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma -- a blood product collected from patients recovered from…

While a large meta-analysis of studies on convalescent plasma use early in the pandemic turned…

Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study…